PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Structural Biology of Disease Processes Laboratory, Francis Crick Institute, NW1 1AT, London, UK. antoni.wrobel@crick.ac.uk.\', \'Structural Biology of Disease Processes Laboratory, Francis Crick Institute, NW1 1AT, London, UK. donald.benton@crick.ac.uk.\', \'Worldwide Influenza Centre, Francis Crick Institute, NW1 1AT, London, UK.\', \'Structural Biology Science Technology Platform, Francis Crick Institute, NW1 1AT, London, UK.\', \'Structural Biology of Cells and Viruses Laboratory, Francis Crick Institute, NW1 1AT, London, UK.\', \'Structural Biology of Disease Processes Laboratory, Francis Crick Institute, NW1 1AT, London, UK.\', \'Structural Biology of Disease Processes Laboratory, Francis Crick Institute, NW1 1AT, London, UK. steven.gamblin@crick.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-020-19146-5
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33087721
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all